脂质皮质硬化和肺高血压在全身性硬化中
Srijana Davuluri1, Puneet Kapoor1, Swarna Nandyala1
1Division of Immunology and Rheumatology, Stanford School of Medicine, Palo Alto, California.
JAMA dermatology
|October 16, 2024
概括
脂质皮质硬化 (LDS) 在全身性硬化 (SSc) 中很少见,但与肺高血压有关. 患有LDS的患者需要密切监测和查这种严重的血管并发症.
科学领域:
- 类风湿病学 类风湿病学
- 皮肤病学 皮肤病学
- 血管医学 血管医学
背景情况:
- 脂质皮质硬化症 (LDS) 与系统性硬化症 (SSc) 具有机械相似之处,原因是血管功能障碍和皮肤炎症.
- 在现有的文献中,LDS和SSc之间的临床关联尚未得到充分证实.
研究的目的:
- 确定SSc.患者中LDS的患病率.
- 研究SSc患者的LDS和血管并发症,特别是肺高血压之间的关联.
主要方法:
- 使用前性收集的纵向数据进行回顾性队列研究.
- 包括从第三级护理中心诊断出SSc的成年患者 (2004年11月 - 2022年11月).
- 临床诊断的LDS通过专家意见或他的病理学证实.
主要成果:
- 在567名SSc患者中,LDS存在于4.4%的患者中.
- 患有LDS的患者表现出显著更高的心律失常,心力衰竭和肺高血压率.
- LDS独立地与肺高血压相关 (aOR,3.10;95% CI,1.33-7.25).
结论:
- 脂质皮质硬化是SSc患者中罕见但重要的发现.
- 在SSc中LDS的存在与肺高血压风险增加有关.
- 建议在被诊断为LDS的SSc患者中对肺高血压进行警监测和查.
更多相关视频
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
152
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
152
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Cardiomyopathy IV: Restrictive Cardiomyopathy
2
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
2
Peripheral Artery Disease I: Introduction
3
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
3
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1


